BioCatalystWatch
PPBTWorkspace / PPBT / OverviewCompany library

PURPLE BIOTECH LTD.

PURPLE BIOTECH LTD. (PPBT)

Price
Market cap
Next catalystH1 2027, subject to regulatory clearanceIM1240 · Trial initiationCompany source ↗
Cash

Chart & Events

Candle interval

Core Clinical

IM1240

CD3 × 5T4 × NKG2A

PreINDP2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

IM1240

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

IM1240

CD3 × 5T4 × NKG2A

PreINDP2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

Other pipelines

IM1305

CD3 × TROP2 × NKG2A

Upcoming / outlook

History / paused

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Company funding outlook

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Source and basis

Source and basis

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

PPBT PR & News

PR & News

PPBT SEC archive